Model Number PVS23 |
Device Problem
Incomplete Coaptation (2507)
|
Patient Problems
Aortic Valve Insufficiency/ Regurgitation (4450); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Type
malfunction
|
Manufacturer Narrative
|
H3 other text : valve remains implanted.
|
|
Event Description
|
A perceval valve size 23 was implanted in a patient on 04 sep 2023.It was noted by echo that 2 of the leaflets of the valve were not working.Based on the information received, the type of re-intervention that going to be performed is still unknown.No further information is available at this time.
|
|
Event Description
|
A perceval valve size 23 was implanted in a patient with stenotic native valve on (b)(6) 2023 through full sternotomy.It was noted by echo that 2 of the leaflets of the valve were not working.Based on the further information received, no leak was noted, and there is still no plan for the re-intervention to be performed.Reportedly, patient was discharged from hospital after thrombolysis with heparin therapy.Cabg, laac, tap was performed concomitantly before perceval implant.Annulus size was about 23.4 mm.Reportedly, no problem was noted in tee and tte, no malposition, and mis-sizing were noted.Furthermore, there was no abnormal geometries in patient's anatomy.
|
|
Manufacturer Narrative
|
The manufacturing and material records for the perceval heart valve, model # icv1209, s/n # (b)(6) , as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve has been manufactured and controlled in accordance with the specifications for a model # icv1209 perceval heart valve at the time of manufacture and release.Steady flow test review was also performed, the images demonstrated the acceptable opened and closed leaflet performance of the perceval pvs23 sn# b23801.No anomalies were observed during the open/close cycle.The valve therefore meets the acceptance criteria of the steady flow test inspection defined in dedicated procedure at the time of release.Based on the limited information available, the definitive root cause of the reported event cannot be established.Hower, from the document review performed, no manufacturing deficiencies were noted.It should be noted that no re-intervention has planned to be performed yet at this time and patient has been discharged after anticoagulation therapy.As such, no further investigation is possible, and cause of the event cannot be established at this time.Should further information be received in the future, a follow up report will be provided.
|
|
Search Alerts/Recalls
|
|